
Steve brings 20+ years in pharma and biotech, from launching therapies at Novo Nordisk and J&J to leading Provell Pharma, with $50M+ impact. Backed by an extensive network, he helps teams align people, systems, and processes to turn strategy into action, all while helping bring therapies to patients faster.
CatalysRX Consulting, LLC
210 Crossings Blvd | PMB-219 | Elverson, PA 19520
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.